Aviscumine Completed Phase 2 Trials for Melanoma Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00658437 | CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy |